Thursday, June 5, 2025
VISIT ROYALMOK
Agarwood Times
  • Home
  • Agarwood
  • Health
  • Diseases
  • Diet & Fitness
  • Nutrition
  • Sleep Info
  • Meditation
  • Shop
No Result
View All Result
  • Home
  • Agarwood
  • Health
  • Diseases
  • Diet & Fitness
  • Nutrition
  • Sleep Info
  • Meditation
  • Shop
No Result
View All Result
Agarwood Times
No Result
View All Result

CRISPR stocks, FDA staff cuts, Bluebird Bio

February 21, 2025
in Health
Reading Time: 5 mins read
0 0
A A
0
Home Health
Share on FacebookShare on Twitter



Wish to keep on prime of the science and politics driving biotech in the present day? Enroll to get our biotech publication in your inbox.

Hi there! Right this moment, we see the CDC’s path ahead with vaccines beginning to look extra sophisticated, pay attention to the chilly reception Pfizer CEO Albert Bourla received on the White Home, and extra.

Bluebird Bio sells itself to funding companies, avoids chapter

From STAT’s Jason Mast: Bluebird Bio introduced this morning it will promote itself and its portfolio of gene therapies to the funding companies Carlyle and SK Capital for lower than $30 million, in a deal that lets the beleaguered biotech keep away from chapter.

Bluebird shareholders will obtain round $3 per share however can receive one other $6.87 per share in a contingent worth proper, or CVR, if Bluebird’s portfolio of therapies begin to turn into commercially profitable, bringing in a minimum of $600 million per 12 months by 2027.

The corporate had entered in the present day with a market cap of $68.4 million and was more and more in peril of merely operating out of money.

It’s sale to personal fairness marks a quiet finish for the biotech, that over the course of a dizzying decade, showcased each the facility of contemporary genetic medication to ship cures for devastating uncommon ailments and the profound challenges any firm would face in turning that energy right into a sustainable enterprise.

Learn extra.

Gene-editing shares are creeping again up

Additionally from Jason Mast: Within the final couple of days, traders in gene-editing corporations have gotten a few of their first reduction in an extended whereas: CRISPR shares are literally, shockingly, ever-so-slightly up. CRISPR Therapeutics is up 15% during the last 5 days. Intellia is up practically 30%. Editas Medication, which had plummeted to almost a $1 per share amid repeated turnover and technique modifications, virtually tripled earlier than settling right down to a roughly $2 plateau.

It’s a welcome raise for the businesses and their backers after practically three years of plummeting valuations throughout the sector. However it’s a tad head-scratching. Not one of the elements which have held down the sphere — supply challenges, reimbursement questions, competitors from extra typical medicines, excessive rates of interest — have modified. No new knowledge have been introduced.

Markets, after all, generally do bizarre issues. Nevertheless it’s attainable this can be a signal the gene-editing sector has lastly bottomed out. Traders had taken a major quick place, over 20%, in every of these corporations. In the event that they closed out these positions, by buying the now hyper-deflated shares, it will increase valuations — briefly a minimum of.

A clumsy second for Bourla in Washington

Albert Bourla, the Pfizer CEO and incoming chairman of the commerce group PhRMA, was in Washington yesterday to fulfill with President Trump on the White Home.

Each side remained tight-lipped in regards to the closed-door discussions, however Bourla joined Trump within the afternoon at a public occasion marking Black Historical past Month. Talking to the viewers gathered within the East Room of the White Home, Trump welcomed Bourla.

“We even have the pinnacle of Pfizer right here, so I need to thank him,” Trump mentioned, singling the CEO out within the viewers. “One of many nice, nice folks, one of many nice businessmen.”

The gang was much less enthused, and instantly started booing — a reminder that even when drugmakers can discover their manner into Trump’s good graces, work stays to be accomplished by the business on public perceptions.

CDC’s vaccine efforts appear headed for a shakeup

The way forward for the CDC’s vaccine advisory committee appears unsure: A scheduled February assembly for the ACIP, which advises the company on vaccine coverage and whose selections insurance coverage protection, has been postponed, STAT’s Helen Branswell stories.

It was to be the panel’s first assembly to happen beneath the Trump administration and HHS Secretary Robert F. Kennedy, Jr., who has criticized the ACIP. The cancellation additionally got here as Politico reported that Kennedy might substitute members he perceives to have conflicts of curiosity.

A U.S. official mentioned the assembly could be rescheduled however vaccine specialists’ considerations weren’t allayed. “That is step 1 of making an attempt to get rid of CDC as a gaggle that makes [vaccine] suggestions,” mentioned Paul Offit, an infectious ailments skilled at Youngsters’s Hospital of Philadelphia.

In the meantime, Helen stories, HHS has ordered the CDC to halt some paid promotions for vaccines so it might refocus on selling the thought of “knowledgeable consent” in vaccine decision-making as an alternative.

Learn extra in regards to the cancelled assembly.

And extra in regards to the shelved vaccine advertisements.

Stanford researchers have developed a software that may analyze immune cell receptors to diagnose ailments like Covid-19, HIV, flu, lupus, and sort 1 diabetes by probing the immune system’s reminiscence of previous infections. Their examine, printed in Science, sequenced hundreds of thousands of B and T cells from practically 600 individuals and educated fashions to categorise illness states with over 85% accuracy.

Whereas promising, the machine learning-based take a look at remains to be in early phases and never but medical viable; autoimmune ailments are notably variable and difficult.

“You’re not going to go and get your T cells and B cells sequenced to diagnose whether or not you’ve Covid, proper?” one researcher not concerned within the work instructed STAT. “I believe if, and this can be a massive if, the cells within the blood reveal what’s occurring within the tissues if you don’t have entry to these tissues, this might be a method of diagnosing ailments that beforehand have been very tough to diagnose by means of different means.”

Learn extra.

How will FDA workers cuts have an effect on the drug business?

Are corporations pushing for an excessive amount of weight reduction from new medication? And what is going to carry biotech out of its doldrums? We focus on all that and extra on the newest episode of “The Readout LOUD.”

Mizuho analyst Jared Holz joins to debate Adam’s column on biotech’s darkish interval. We additionally speak about Elaine’s newest article on the push for better and better weight reduction from weight problems medication, together with developments at Strong Biosciences and federal job cuts.

Pay attention right here.

Extra reads

Trump’s Justice Division defends Medicare drug value talks in case introduced by Novartis, STAT

Pfizer says it’ll finish international improvement of hemophilia gene remedy Beqvez, Reuters

Fueled by pandemic frustrations, populist events are embracing anti-vaccine figures abroad, too, STAT

Dozens of attorneys basic urge FDA to crack down on counterfeit weight problems medication, STAT



Source link

Tags: BioBluebirdCRISPRcutsFDAstaffstocks
Previous Post

Agarwood seeds for planting – Agarwood plant nursery – Agor tree in assam #plants

Next Post

Talking Sleep | KPAP: Exploring a Novel PAP Therapy Approach

Related Posts

Diabetes drug shows benefits for patients with liver disease
Health

Diabetes drug shows benefits for patients with liver disease

June 4, 2025
Household environments may affect the likelihood of children developing eczema
Health

Household environments may affect the likelihood of children developing eczema

June 4, 2025
UnitedHealth accidentally emails internal talking points to reporter
Health

UnitedHealth accidentally emails internal talking points to reporter

June 5, 2025
Scripta Insights, RxSaveCard partner for lower prescription drug costs
Health

Scripta Insights, RxSaveCard partner for lower prescription drug costs

June 5, 2025
Trump’s Cognitive ‘Decline’ Suggests He ‘Might Not Make It Through Four Years,’ Republican Strategist Says
Health

Trump’s Cognitive ‘Decline’ Suggests He ‘Might Not Make It Through Four Years,’ Republican Strategist Says

June 4, 2025
Monoclonal antibody halves hospitalizations of children younger than 6 months old
Health

Monoclonal antibody halves hospitalizations of children younger than 6 months old

June 3, 2025
Next Post
Talking Sleep | KPAP: Exploring a Novel PAP Therapy Approach

Talking Sleep | KPAP: Exploring a Novel PAP Therapy Approach

Can baby bonds reduce childhood poverty? California thinks so | California

Can baby bonds reduce childhood poverty? California thinks so | California

Four countries report new polio cases

Four countries report new polio cases

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED

Household environments may affect the likelihood of children developing eczema
Health

Household environments may affect the likelihood of children developing eczema

by admin
June 4, 2025
0

Family environments, together with proudly owning a canine, could have an effect on the chance of kids creating eczema, in...

Saving Lives and Stopping Super Speeders with Intelligent Speed Assistance Technology

Saving Lives and Stopping Super Speeders with Intelligent Speed Assistance Technology

June 1, 2025
Antibiotic Resistance, Cultivated Meat, and Our Health

Antibiotic Resistance, Cultivated Meat, and Our Health

June 3, 2025
A tragic paradox, Gilead updates, and lots of Pfizer news

A tragic paradox, Gilead updates, and lots of Pfizer news

June 1, 2025
Report highlights evidence, remaining data gaps on vaccines and antibiotic resistance

Report highlights evidence, remaining data gaps on vaccines and antibiotic resistance

June 3, 2025
U.S. Global Health Legislation Tracker

U.S. Global Health Legislation Tracker

June 4, 2025
Facebook Twitter Instagram Youtube RSS
Agarwood Times

Stay informed with the latest news, articles, and insights on agarwood cultivation, history, sustainability, and more. Explore the timeless allure of agarwood and deepen your understanding of this extraordinary natural resource.

CATEGORIES

  • Agarwood
  • Diet & Fitness
  • Diseases
  • Health
  • Meditation
  • Nutrition
  • Sleep Info
  • Uncategorized
No Result
View All Result

SITEMAP

  • About us
  • Advertise With Us
  • Disclaimer
  • Privacy Policy
  • DMCA
  • Cookie Privacy Policy
  • Terms and Conditions
  • Contact us

Copyright © 2024 Agarwood Times.
Agarwood Times is not responsible for the content of external sites.

No Result
View All Result
  • Home
  • Agarwood
  • Health
  • Diseases
  • Diet & Fitness
  • Nutrition
  • Sleep Info
  • Meditation
  • Shop
VISIT ROYALMOK

Copyright © 2024 Agarwood Times.
Agarwood Times is not responsible for the content of external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In